〇論文投稿例

Accept
1. Cell Metabolism, Editorial reject→J Clin Invest, Editorial reject→データ増量→Cell Metabolism, Editorial reject(7日後)→J Clin Invest, Editorial reject (8日後)→Nat Commun, Editorial reject (15日後)→Diabetes, Accept
2. Endocrinology, 条件付きreject→J Biol Chem, Reviewer reject (15日後)→データ増量→先行論文publish→Endocrinology, Editorial accept (20日後)
3. Endocr J., reviewer reject→Intern Med, Accept
4. Endocr J, Editorial reject→Intern Med, Reviewer reject→Clin Case Rep, Reviewer reject (4か月後)→Case Reports in Endocrinology, major revision (102日後)→accept
5. Nat Commun, Editorial reject (Sci Rep transfer)→Cell Reports, Editorial reject (iScience transfer)→eLife, 条件付きreject (11日後)→Endocrinology, 条件付きreject→データ増量→PNAS, Editorial reject→EMBO J., editorial reject (Life Sci Alliance transfer)→Endocrinology, Reviewer reject (Editor交代後)→J Biol Chem., Reviewer reject→EMBO Rep., Editorial Reject→JCI Insight, Accept
6. JCEM Case Rep, Revision→Editorial reject→Enodocr J., Reviewer reject→Case Reports in Endocrinology, Acccept
7. Cell Metabolism, Editorial reject (iScience transfer提案)→J Clin Invest, Editorial reject→Nat Commun, Editorial reject (Commun Biolのreview保証)→Cell Reports, Reviewer reject (Metabolism/Molecular Metabolismにrevisionとしてtransfer提案)→Metabolism, Reviewer reject (Diabetes Res Clin Practにtransfer提案)→iScience, リバイス提案され撤回→eLife, reject (25日後)→J Biol Chem, Accept
8. Nat Metab, Editorial reject (npj Metabolic Health and Diseaseのreview保証)→Nat Commun, Editorial reject (Commun Biolのreview保証。無期限)→J Clin Invest, Editorial reject (1週後に、JCI Insightへのreview保証)

Pending
1. J Clin Endocrinol Metab, Editorial reject+transfer提案→J Endocr Soc, Reviewer reject